Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
McKesson
Colorcon
Mallinckrodt
AstraZeneca

Last Updated: May 26, 2022

Investigational Drug Information for GDC-0084


✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for GDC-0084?

GDC-0084 is an investigational drug.

There have been 186 clinical trials for GDC-0084. The most recent clinical trial was a Phase 3 trial, which was initiated on January 8th 2013.

The most common disease conditions in clinical trials are Breast Neoplasms, Carcinoma, and Lymphoma. The leading clinical trial sponsors are Genentech, Inc., National Cancer Institute (NCI), and Hoffmann-La Roche.

Recent Clinical Trials for GDC-0084
TitleSponsorPhase
Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung CancerNational Cancer Institute (NCI)Phase 1
Testing the Safety and Efficacy of the Addition of A New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Etoposide and Cisplatin) for Adult and Pediatric Patients (12-17 Years) With NUT CarcinomaNational Cancer Institute (NCI)Phase 1/Phase 2
Combination Therapy for the Treatment of Diffuse Midline GliomasMithil Prasad FoundationPhase 2

See all GDC-0084 clinical trials

Clinical Trial Summary for GDC-0084

Top disease conditions for GDC-0084
Top clinical trial sponsors for GDC-0084

See all GDC-0084 clinical trials

International Patents for GDC-0084

Drugname Country Document Number Estimated Expiration Related US Patent
GDC-0084 Argentina AR084312 2030-12-16 See Plans and Pricing
GDC-0084 Australia AU2011343712 2030-12-16 See Plans and Pricing
GDC-0084 Australia AU2015268776 2030-12-16 See Plans and Pricing
GDC-0084 Brazil BR112013014914 2030-12-16 See Plans and Pricing
GDC-0084 Canada CA2820078 2030-12-16 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
McKesson
Colorcon
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.